Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia.

Clinical trial NCT01571635 · TERMINATED

Trial details

NCT number: NCT01571635
Sponsor: Celgene
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Beta Thalassemia Major Beta Thalassemia Intermedia

Start date: 2012-10-10
Primary completion: 2015-07-02
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.